Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China

Tao Luo, Ming Zhao, Xia Li, Peng Xu, Xiaohong Gui, Sam Pickerill, Kathryn DeRiemer, Jian Mei, Qian Gao

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Novel tools are urgently needed for the rapid, reliable detection of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. To develop such tools, we need information about the frequency and distribution of the mycobacterial mutations and genotypes that are associated with phenotypic drug resistance. In a population-based study, we sequenced specific genes of M. tuberculosis that were associated with resistance to rifampin and isoniazid in 242 phenotypically MDR isolates and 50 phenotypically pan-susceptible isolates from tuberculosis (TB) cases in Shanghai, China. We estimated the sensitivity and specificity of the mutations, using the results of conventional, culture-based phenotypic drug susceptibility testing as the standard. We detected mutations within the 81-bp core region of rpoB in 96.3% of phenotypically MDR isolates. Mutations in two structural genes (katG and inhA) and two regulatory regions (the promoter of mabA-inhA and the intergenic region of oxyR-ahpC) were found in 89.3% of the MDR isolates. In total, 88.0% (213/242 strains) of the phenotypic MDR strains were confirmed by mutations in the sequenced regions. Mutations in embB306 were also considered a marker for MDR and significantly increased the sensitivity of the approach. Based on our findings, an approach that prospectively screens for mutations in 11 sites of the M. tuberculosis genome (rpoB531, rpoB526, rpoB516, rpoB533, and rpoB513, katG315, inhA-15, ahpC-10, ahpC-6, and ahpC-12, and embB306) could detect 86.8% of MDR strains in Shanghai. This study lays the foundation for the development of a rapid, reliable molecular genetic test to detect MDR strains of M. tuberculosis in China.

Original languageEnglish (US)
Pages (from-to)1075-1081
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume54
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Multidrug-Resistant Tuberculosis
Mycobacterium tuberculosis
China
Mutation
Intergenic DNA
Nucleic Acid Regulatory Sequences
Isoniazid
Rifampin
Drug Resistance
Pharmaceutical Preparations
Genes
Molecular Biology
Tuberculosis
Genotype
Genome
Sensitivity and Specificity
Population

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. / Luo, Tao; Zhao, Ming; Li, Xia; Xu, Peng; Gui, Xiaohong; Pickerill, Sam; DeRiemer, Kathryn; Mei, Jian; Gao, Qian.

In: Antimicrobial Agents and Chemotherapy, Vol. 54, No. 3, 03.2010, p. 1075-1081.

Research output: Contribution to journalArticle

Luo, T, Zhao, M, Li, X, Xu, P, Gui, X, Pickerill, S, DeRiemer, K, Mei, J & Gao, Q 2010, 'Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China', Antimicrobial Agents and Chemotherapy, vol. 54, no. 3, pp. 1075-1081. https://doi.org/10.1128/AAC.00964-09
Luo, Tao ; Zhao, Ming ; Li, Xia ; Xu, Peng ; Gui, Xiaohong ; Pickerill, Sam ; DeRiemer, Kathryn ; Mei, Jian ; Gao, Qian. / Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. In: Antimicrobial Agents and Chemotherapy. 2010 ; Vol. 54, No. 3. pp. 1075-1081.
@article{0c81b9708cfc4fdc967d19902aaaaf2c,
title = "Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China",
abstract = "Novel tools are urgently needed for the rapid, reliable detection of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. To develop such tools, we need information about the frequency and distribution of the mycobacterial mutations and genotypes that are associated with phenotypic drug resistance. In a population-based study, we sequenced specific genes of M. tuberculosis that were associated with resistance to rifampin and isoniazid in 242 phenotypically MDR isolates and 50 phenotypically pan-susceptible isolates from tuberculosis (TB) cases in Shanghai, China. We estimated the sensitivity and specificity of the mutations, using the results of conventional, culture-based phenotypic drug susceptibility testing as the standard. We detected mutations within the 81-bp core region of rpoB in 96.3{\%} of phenotypically MDR isolates. Mutations in two structural genes (katG and inhA) and two regulatory regions (the promoter of mabA-inhA and the intergenic region of oxyR-ahpC) were found in 89.3{\%} of the MDR isolates. In total, 88.0{\%} (213/242 strains) of the phenotypic MDR strains were confirmed by mutations in the sequenced regions. Mutations in embB306 were also considered a marker for MDR and significantly increased the sensitivity of the approach. Based on our findings, an approach that prospectively screens for mutations in 11 sites of the M. tuberculosis genome (rpoB531, rpoB526, rpoB516, rpoB533, and rpoB513, katG315, inhA-15, ahpC-10, ahpC-6, and ahpC-12, and embB306) could detect 86.8{\%} of MDR strains in Shanghai. This study lays the foundation for the development of a rapid, reliable molecular genetic test to detect MDR strains of M. tuberculosis in China.",
author = "Tao Luo and Ming Zhao and Xia Li and Peng Xu and Xiaohong Gui and Sam Pickerill and Kathryn DeRiemer and Jian Mei and Qian Gao",
year = "2010",
month = "3",
doi = "10.1128/AAC.00964-09",
language = "English (US)",
volume = "54",
pages = "1075--1081",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China

AU - Luo, Tao

AU - Zhao, Ming

AU - Li, Xia

AU - Xu, Peng

AU - Gui, Xiaohong

AU - Pickerill, Sam

AU - DeRiemer, Kathryn

AU - Mei, Jian

AU - Gao, Qian

PY - 2010/3

Y1 - 2010/3

N2 - Novel tools are urgently needed for the rapid, reliable detection of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. To develop such tools, we need information about the frequency and distribution of the mycobacterial mutations and genotypes that are associated with phenotypic drug resistance. In a population-based study, we sequenced specific genes of M. tuberculosis that were associated with resistance to rifampin and isoniazid in 242 phenotypically MDR isolates and 50 phenotypically pan-susceptible isolates from tuberculosis (TB) cases in Shanghai, China. We estimated the sensitivity and specificity of the mutations, using the results of conventional, culture-based phenotypic drug susceptibility testing as the standard. We detected mutations within the 81-bp core region of rpoB in 96.3% of phenotypically MDR isolates. Mutations in two structural genes (katG and inhA) and two regulatory regions (the promoter of mabA-inhA and the intergenic region of oxyR-ahpC) were found in 89.3% of the MDR isolates. In total, 88.0% (213/242 strains) of the phenotypic MDR strains were confirmed by mutations in the sequenced regions. Mutations in embB306 were also considered a marker for MDR and significantly increased the sensitivity of the approach. Based on our findings, an approach that prospectively screens for mutations in 11 sites of the M. tuberculosis genome (rpoB531, rpoB526, rpoB516, rpoB533, and rpoB513, katG315, inhA-15, ahpC-10, ahpC-6, and ahpC-12, and embB306) could detect 86.8% of MDR strains in Shanghai. This study lays the foundation for the development of a rapid, reliable molecular genetic test to detect MDR strains of M. tuberculosis in China.

AB - Novel tools are urgently needed for the rapid, reliable detection of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. To develop such tools, we need information about the frequency and distribution of the mycobacterial mutations and genotypes that are associated with phenotypic drug resistance. In a population-based study, we sequenced specific genes of M. tuberculosis that were associated with resistance to rifampin and isoniazid in 242 phenotypically MDR isolates and 50 phenotypically pan-susceptible isolates from tuberculosis (TB) cases in Shanghai, China. We estimated the sensitivity and specificity of the mutations, using the results of conventional, culture-based phenotypic drug susceptibility testing as the standard. We detected mutations within the 81-bp core region of rpoB in 96.3% of phenotypically MDR isolates. Mutations in two structural genes (katG and inhA) and two regulatory regions (the promoter of mabA-inhA and the intergenic region of oxyR-ahpC) were found in 89.3% of the MDR isolates. In total, 88.0% (213/242 strains) of the phenotypic MDR strains were confirmed by mutations in the sequenced regions. Mutations in embB306 were also considered a marker for MDR and significantly increased the sensitivity of the approach. Based on our findings, an approach that prospectively screens for mutations in 11 sites of the M. tuberculosis genome (rpoB531, rpoB526, rpoB516, rpoB533, and rpoB513, katG315, inhA-15, ahpC-10, ahpC-6, and ahpC-12, and embB306) could detect 86.8% of MDR strains in Shanghai. This study lays the foundation for the development of a rapid, reliable molecular genetic test to detect MDR strains of M. tuberculosis in China.

UR - http://www.scopus.com/inward/record.url?scp=77149123612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149123612&partnerID=8YFLogxK

U2 - 10.1128/AAC.00964-09

DO - 10.1128/AAC.00964-09

M3 - Article

VL - 54

SP - 1075

EP - 1081

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 3

ER -